Steve Schonfeld’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Steve Schonfeld’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-275,000	Closed	-$27.6M	–	2662
2025 Q3	$27.6M	Buy	+275,000	New	+$24.8M	0.16%	122
2024 Q3	–	Sell	-300,000	Closed	-$27.8M	–	2472
2024 Q2	$27.8M	Buy	+300,000	New	+$26.9M	0.18%	107
2024 Q1	–	Sell	-600,000	Closed	-$53.6M	–	2456
2023 Q4	$53.6M	Hold	600,000	–	–	0.36%	28
2023 Q3	$43.8M	Hold	600,000	–	–	0.34%	48
2023 Q2	$1.52M	Buy	+600,000	New	+$50.2M	0.01%	850
2022 Q1	–	Sell	-50,000	Closed	-$5.6M	–	2961
2021 Q4	$5.6M	Sell	50,000 -50,000	-50%	-$6.03M	0.05%	431
2021 Q3	$12.6M	Buy	+100,000	New	+$12.9M	0.13%	206

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Steve Schonfeld's XBI Position: Q2 2026 in Review

Steve Schonfeld increased its State Street SPDR S&P Biotech ETF (XBI) stake by 37% in Q2 2026, buying an estimated $382K and bringing the position to 10,471 shares worth $1.66M. The position accounts for 0.01% of the portfolio, ranked #1171.

Steve Schonfeld first reported a position in XBI in Q3 2020 and has held it in 20 quarters since. The position peaked at $31M in Q2 2023. 931 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Steve Schonfeld held 10,471 shares of State Street SPDR S&P Biotech ETF worth $1.66M as of Q2 2026.
Steve Schonfeld bought 2,828 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $382K.
State Street SPDR S&P Biotech ETF made up 0.01% of Steve Schonfeld's portfolio in Q2 2026, its #1171 holding.
Steve Schonfeld first reported a position in State Street SPDR S&P Biotech ETF in Q3 2020 and has held it in 20 quarters since.
Steve Schonfeld's State Street SPDR S&P Biotech ETF position peaked at $31M in Q2 2023.
931 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.